The CIBMTR Research ID (CRID) is a unique identifier assigned when an individual is registered with CIBMTR as receiving a cellular therapy, including hematopoietic stem cell transplant (HCT), cellular therapy (CT), treatment for marrow toxic injuries, or certain non-cellular therapies. The CRID Assignment Tool 2804 collects the information required to create a lifelong identification number specific to an individual, and certain data fields are used to ensure that the same individual does not inadvertently receive multiple CRID assignments.

By creating a unique identifier and ensuring participants receive only a single CRID, CIBMTR is better able to carry out its charge as a co-contractor of the C.W. Bill Young Transplantation Program with the responsibility for maintaining the Stem Cell Therapeutic Outcomes Database (SCTOD). The CRID is used to ensure the accuracy of center-specific outcomes by adjusting survival expectation for patients receiving multiple HCTs and allowing for verification of survival status within the National Death Index. Additionally, the CRID can be used to help re-establish contact with individuals who are lost to follow-up and to ensure that all allogeneic HCT recipients in the US, or receive a product from the US, are reported to CIBMTR.

Completeness of the Form 2804 is important for ensuring that individuals are not assigned multiple CRIDs over their lifetime. The system is able to assign an identification number when some identifying fields are missing, but this increases the risk of duplicate reporting. Therefore, the following guidelines have been established:

  • For all individuals, complete the form as thoroughly as possible
  • In the event of a state law or IRB policy that supersedes federal statute, centers may opt out of providing some of these data

CIBMTR carefully ensures that identifying information is collected and stored in a secure manner. The electronic systems that generate CRIDs have undergone rigorous certification and authorization from HRSA’s Office of Information Technology and they comply with all US regulations relevant to security of data in federal databases.

Once the identifying data are entered into FormsNet3 and a CRID is assigned, the identifying data are held within the CIBMTR Research ID Assignment (2804) Form and are not visible in any other locations in FormsNet3. For that reason, it is important that the information is accurate when submitted. The identifying information used to create the CRID will not appear on any subsequent forms or correspondence.

Transplant centers need to take appropriate measures at their site to secure the identifying information used to generate the CRID.

Q1-13: Demographics
Q14-18: Recipient Identifiers
Q19-22: Outcomes Registry Reporting

Manual Updates:
The most recent updates to the manual can be found below. If you need to reference the historical version for this form, see the retired manual section on the Retired Forms Manuals webpage.

Date Manual Section Add/Remove/Modify Description
3/9/2021 2804: CIBMTR Research ID Assignment Form Add Added the following instructions to question 10: Indicate the detailed race of the recipient. If this recipient has reported that they are more than one detailed race, check each detailed race indicated in the list below that applies. If the race detail is not documented or is not known, select “unknown.”
3/9/2021 2804: CIBMTR Research ID Assignment Form Remove Removed the following instructions from question 9: Indicate the recipient’s race. If this recipient has reported that they are more than one race, check each race indicated in the list below that applies. The race groups provided are specific to the United States. If the recipient is White, Southeast Asian, or Pacific Islander, but a more specific Race Detail is not available, report the patient is “Other [White, Southeast Asian, or Pacific Islander respectively].
Last modified: Aug 22, 2024